Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

the Translational Breast Cancer Research Consortium (TBCRC)

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015'. Together they form a unique fingerprint.

Medicine & Life Sciences